Disease or Syndrome – Page 87

Cartesian Therapeutics Announces Positive Phase 2b Results for Descartes-08 in Myasthenia Gravis Treatment

10 months ago talkbio0Tagged Autoimmune, Autoimmune Diseases, Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes, CAR-T, Cartesian, Myasthenia Gravis, Phase II B Trial

Cartesian Therapeutics, Descartes-08, Myasthenia Gravis, Phase 2b Trial, CAR-T Therapy, Autoimmune Disorder

Annovis Bio Reports Promising Phase III Study Results for Buntanetap in Parkinson’s Disease Treatment

10 months ago talkbio0Tagged Annovis, Bio, buntanetap, Cognition, MDS-UPDRS, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Parkinson 's Disease Rating Scale, Phase 3 Clinical Trials, Unified - Type of Agreement

Annovis Bio, Buntanetap, Parkinson’s Disease, Phase III Study, Neurodegenerative Disorders, Cognitive Function, Motor Functions, Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

Moderna Secures $176 Million BARDA Award for Bird Flu Vaccine Development

10 months ago talkbio0Tagged BARDA, development aspects, Influenza in Birds, Moderna, pandemic preparedness, RNA, Messenger, Vaccines

Moderna, BARDA, Bird Flu, Vaccine Development, mRNA Technology, Pandemic Preparedness

Alumis Completes IPO, Raising $250 Million for Inflammation and Immunology Research

10 months ago talkbio0Tagged Alumis, biotech, Dental Plaque, Immunology, Inflammation, Inhibitor, IPO, Psoriasis, TYK2 gene, Uveitis

Alumis, IPO, Inflammation, Immunology, Biotech, TYK2 Inhibitor, Plaque Psoriasis, Uveitis, Lupus

Savara Raises $100 Million Following Lung Disease Treatment Breakthrough

10 months ago talkbio0Tagged Autoimmune Pulmonary, Lung diseases, PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED, Raise, Savara

Savara, Lung Disease, $100 Million Raise, Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Treatment